Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-026957
Filing Date
2024-07-11
Accepted
2024-07-11 16:15:41
Documents
14
Period of Report
2024-07-01
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 42481
  Complete submission text file 0001493152-24-026957.txt   267371

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdt-20240701.xsd EX-101.SCH 3883
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdt-20240701_def.xml EX-101.DEF 26778
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdt-20240701_lab.xml EX-101.LAB 37007
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdt-20240701_pre.xml EX-101.PRE 25402
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6804
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41245 | Film No.: 241112215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)